Crossmark Global Holdings, Inc. Danaher Corp Transaction History

Crossmark Global Holdings, Inc.

$5.61 Billion
Q3 2024

A detailed history of Crossmark Global Holdings, Inc. transactions in Danaher Corp stock. As of the latest transaction made, Crossmark Global Holdings, Inc. holds 39,841 shares of DHR stock, worth $9.21 Million. This represents 0.2% of its overall portfolio holdings.

Number of Shares

39,841

Previous 40,135 0.73%

Holding current value

$9.21 Million

Previous $10 Million 10.46%

% of portfolio

0.2%

Previous 0.19%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 04, 2024	SELL	$239.25 - $280.76 $70,339 - $82,543	-294 Reduced 0.73%	39,841 $11.1 Million
Q2 2024 Jul 29, 2024	SELL	$235.51 - $267.98 $214,314 - $243,861	-910 Reduced 2.22%	40,135 $10 Million
Q1 2024 May 13, 2024	BUY	$224.58 - $256.19 $214,698 - $244,917	956 Added 2.38%	41,045 $10.2 Million
Q4 2023 Feb 13, 2024	SELL	$185.1 - $233.13 $234,706 - $295,608	-1,268 Reduced 3.07%	40,089 $9.27 Million
Q3 2023 Nov 08, 2023	SELL	$233.08 - $265.59 $53,142 - $60,554	-228 Reduced 0.55%	41,357 $9.05 Million
Q2 2023 Jul 31, 2023	SELL	$224.99 - $256.14 $528,276 - $601,416	-2,348 Reduced 5.34%	41,585 $10.8 Million
Q1 2023 May 12, 2023	SELL	$239.75 - $277.0 $2.47 Million - $2.86 Million	-10,317 Reduced 19.02%	43,933 $11.1 Million
Q4 2022 Jan 19, 2023	BUY	$241.42 - $282.29 $4.76 Million - $5.56 Million	19,713 Added 57.08%	54,250 $14.4 Million
Q3 2022 Nov 01, 2022	SELL	$247.06 - $1507.4 $638,155 - $3.89 Million	-2,583 Reduced 6.96%	34,537 $8.92 Million
Q2 2022 Jul 29, 2022	BUY	$237.11 - $299.66 $315,119 - $398,248	1,329 Added 3.71%	37,120 $9.41 Million
Q1 2022 May 11, 2022	SELL	$257.27 - $315.76 $99,048 - $121,567	-385 Reduced 1.06%	35,791 $10.5 Million
Q4 2021 Jan 10, 2022	SELL	$292.08 - $329.01 $1.01 Million - $1.14 Million	-3,473 Reduced 8.76%	36,176 $11.9 Million
Q3 2021 Oct 21, 2021	SELL	$272.21 - $332.43 $3.45 Million - $4.22 Million	-12,681 Reduced 24.23%	39,649 $12.1 Million
Q3 2021 Oct 13, 2021	BUY	$272.21 - $332.43 $4.09 Million - $4.99 Million	15,007 Added 40.21%	52,330 $2.89 Million
Q2 2021 Jul 21, 2021	SELL	$225.08 - $271.69 $134,822 - $162,742	-599 Reduced 1.58%	37,323 $10 Million
Q1 2021 Apr 15, 2021	SELL	$212.38 - $245.9 $250,820 - $290,407	-1,181 Reduced 3.02%	37,922 $8.54 Million
Q4 2020 Jan 14, 2021	SELL	$212.5 - $245.46 $267,750 - $309,279	-1,260 Reduced 3.12%	39,103 $8.69 Million
Q3 2020 Oct 08, 2020	SELL	$177.16 - $215.33 $284,873 - $346,250	-1,608 Reduced 3.83%	40,363 $8.69 Million
Q2 2020 Aug 14, 2020	SELL	$128.7 - $176.83 $98,712 - $135,628	-767 Reduced 1.79%	41,971 $7.42 Million
Q1 2020 Apr 28, 2020	SELL	$121.39 - $169.05 $2.08 Million - $2.9 Million	-17,140 Reduced 28.62%	42,738 $5.92 Million
Q4 2019 Feb 06, 2020	SELL	$133.47 - $153.48 $364,773 - $419,460	-2,733 Reduced 4.37%	59,878 $9.19 Million
Q3 2019 Oct 09, 2019	BUY	$135.4 - $146.47 $207,297 - $224,245	1,531 Added 2.51%	62,611 $9.04 Million
Q2 2019 Jul 09, 2019	BUY	$124.88 - $143.73 $63,813 - $73,446	511 Added 0.84%	61,080 $8.73 Million
Q1 2019 May 02, 2019	SELL	$97.62 - $132.29 $1.07 Million - $1.45 Million	-10,983 Reduced 15.35%	60,569 $8 Million
Q4 2018 Jan 31, 2019	BUY	$94.85 - $109.54 $288,344 - $333,001	3,040 Added 4.44%	71,552 $7.38 Million
Q3 2018 Nov 08, 2018	SELL	$98.13 - $108.9 $346,889 - $384,961	-3,535 Reduced 4.91%	68,512 $7.45 Million
Q2 2018 Jul 31, 2018	BUY	$96.1 - $103.24 $20,181 - $21,680	210 Added 0.29%	72,047 $7.11 Million
Q1 2018 Apr 16, 2018	SELL	$92.16 - $103.8 $53,913 - $60,723	-585 Reduced 0.81%	71,837 $7.03 Million
Q4 2017 Feb 05, 2018	SELL	$85.26 - $94.62 $20,462 - $22,708	-240 Reduced 0.33%	72,422 $6.72 Million
Q3 2016 Oct 25, 2017	BUY	N/A	72,662	72,662 $6.23 Million

Others Institutions Holding DHR

# of Institutions

2,511

Shares Held

540M

Call Options Held

7.07M

Put Options Held

4.55M

View Full List

About DANAHER CORP

Ticker DHR
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 727,963,008
Market Cap $168B
Description
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...

More about DHR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Crossmark Global Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Crossmark Global Holdings, Inc. with notifications on news.

Account

Crossmark Global Holdings, Inc. Danaher Corp Transaction History